SEI Investments
LJPC

SEI Investments’s La Jolla Pharmaceutical Company LJPC Stock Holding History

SEI Investments’s Portfolio LJPC Stock Details LJPC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-1
Closed – – 3908
2018
Q2 		$0 Sell
1
-999
-100% -$30.8K ﹤0.01% 4011
2018
Q1 		$30K Sell
1,000
-123
-11% -$3.97K ﹤0.01% 2528
2017
Q4 		$36K Buy
1,123
+117
+12% +$3.82K ﹤0.01% 2451
2017
Q3 		$35K Buy
1,006
+779
+343% +$25.1K ﹤0.01% 2362
2017
Q2 		$7K Buy
227
+18
+9% +$516 ﹤0.01% 2690
2017
Q1 		$6K Buy
+209
New +$5.34K ﹤0.01% 2569
2015
Q4 		– Sell
-8,369
Closed -$233K – 2931
2015
Q3 		$233K Buy
+8,369
New +$264K ﹤0.01% 1567

Other funds holding LJPC

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
SCM
Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

SEI Investments's LJPC Position: Q3 2018 in Review

SEI Investments sold out of La Jolla Pharmaceutical Company (LJPC) in Q3 2018, closing a stake of 1 share.

SEI Investments first reported a position in LJPC in Q3 2015 and held it in 7 quarters. The position peaked at $233K in Q3 2015. 78 funds tracked by Wall St. Rank hold LJPC as of Q3 2018.

  • SEI Investments reported no remaining La Jolla Pharmaceutical Company position as of Q3 2018 after selling out during the quarter.
  • SEI Investments sold 1 La Jolla Pharmaceutical Company share in Q3 2018.
  • SEI Investments first reported a position in La Jolla Pharmaceutical Company in Q3 2015 and held it in 7 quarters.
  • SEI Investments's La Jolla Pharmaceutical Company position peaked at $233K in Q3 2015.
  • 78 funds tracked by Wall St. Rank held La Jolla Pharmaceutical Company as of Q3 2018.

Based on SEI Investments's 13F filing for Q3 2018, filed 8 Nov 2018.